Migraine Treatment Market Report 2026

Migraine Treatment Market Overview

• Migraine Treatment market size has reached to $3.45 billion in 2025 • Expected to grow to $5.8 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Impact of Prolonged Screen Exposure on the Migraine Treatment Market • Market Trend: Increasing Focus On Product Approvals To Provide Reliable Services To Their Customers • North America was the largest region in 2025.

What Is Covered Under Migraine Treatment Market?

A migraine is a neurological condition, with the most prominent symptom being a throbbing, pulsating headache on one side of the brain. Migraine treatment is used to treat a headache that often affects one side of the head and can be extremely painful, throbbing, or pulsating by blocking the pathways in the brain that cause pain. With the help of migraine treatment, future attacks and migraine symptoms can be stopped. The main types of migraine treatment are episodic, migraine with aura, chronic, and other types. Episodic migraine treatment is used to treat a migraine in which an individual suffers from a headache that lasts for 0–14 days per month. Several acute treatment options are used to treat episodic migraine. The treatments for migraine include acute/abortive treatment, preventive/prophylactic treatment, and non-pharmacological therapies and devices that are used in hospitals, clinics, homecare, and by other end-users.

What Is The Migraine Treatment Market Growth Forecast?

The migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $5.8 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to development of new cgrp inhibitors, increasing adoption of digital therapeutics, rising demand for home-based care solutions, growth in wearable device usage for migraine tracking, expansion of personalized treatment programs. Major trends in the forecast period include expansion of precision medicine approaches for migraine prevention, AI-based migraine detection and forecasting tools, growth of digital symptom tracking platforms, integration of iot-enabled wearable devices for migraine monitoring, use of vr/ar for pain distraction therapy.

Global Migraine Treatment Market Segmentation

1) By Type: Episodic, Migraine With Aura, Chronic, Other Types 2) By Treatment: Acute Or Abortive Treatment, Preventive Or Prophylactic Treatment, Non-Pharmacological Therapies And Devices 3) By End-User: Hospitals, Clinics, Homecare, Other End-Users Subsegments: 1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine 2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura 3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura 4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine

What Is The Driver Of The Migraine Treatment Market?

The prolonged screen exposure is expected to propel the growth of the migraine treatment market. Screen exposure refers to the amount of time individuals spend interacting with electronic screens, such as those on smartphones, tablets, computers, and televisions. Prolonged screen exposure is driven by factors such as increased remote work, online education, digital entertainment, and the growing reliance on technology for social interaction. Migraine treatment manages migraine symptoms triggered or worsened by extended screen time, including medications, lifestyle modifications, and the use of ergonomic practices to minimize strain and prevent attacks. For instance, in November 2023, according to the office of communications, a UK-based, in May 2023, UK adults spent an average of 3 hours and 41 minutes online daily, a slight increase of eight minutes compared to May 2022. During this period, 47.9 million adults accessed the internet across smartphones, tablets, and computers. Young adults aged 18–24 were the heaviest users, averaging 4 hours and 36 minutes per day, while those aged 65 and above spent the least time online. Therefore, the prolonged screen exposure is driving the growth of the migraine treatment industry.

Key Players In The Global Migraine Treatment Market

Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., Novartis AG, Bayer AG, Allergan PLC, Allodynic Therapeutics LLC, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., Johnson & Johnson Inc., Teva Pharmaceutical Industries Ltd., H Lundbeck A/S, Axsome Therapeutics Inc., Zosano Pharma Inc., Satsuma Pharmaceuticals Inc., AEON Biopharma Inc., Pulmatrix Inc., Vaxxinity Inc., Ionis Pharmaceuticals Inc., Charleston Laboratories LLC, Merz Therapeutics, Ipsen, Kallyope Inc., Nuvie Bio LLC.

Global Migraine Treatment Market Trends and Insights

Major companies operating in the migraine treatment market are focusing on product approvals, such as Zavzpret (zavegepant) migraine nasal spray, to drive revenues in their market. Zavzpret is the calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute management of adult migraines. For instance, in March 2023, Pfizer Inc., a US-based pharmaceutical corporation, received FDA approval for zavzpret (zavegepant). Zavegepant, also known as zavzpret, is a nasal spray that is used for the immediate treatment of adult migraine attacks with or without symptoms. This was intended to provide pain relief with a single spray. The FDA's approval of Zavzpret represents a major advancement for migraine sufferers who desire an alternative to oral drugs and need pain relief.

What Are Latest Mergers And Acquisitions In The Migraine Treatment Market?

In July 2023, Tonix Pharmaceuticals Holding Corp., a US-based biopharmaceutical company, acquired two marketed migraine products, Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg, from Upsher-Smith Laboratories, LLC, for an undisclosed amount. Through this acquisition, Tonix aims to expand its migraine treatment portfolio and enhance its ability to provide acute migraine therapies to patients. Upsher-Smith Laboratories, LLC is a US-based pharmaceutical company that develops and markets prescription drugs across multiple therapeutic areas, including migraine treatments.

Regional Outlook

North America was the largest region in the migraine treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Migraine Treatment Market?

The migraine treatment market includes revenues earned by entities by providing branded and generic migraine treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Migraine Treatment Market Report 2026?

The migraine treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the migraine treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.